Center of expertise for rare diseases

Last updated

A Center of expertise for rare diseases is a physical expert structure for the management and care of rare disease patients. [1] In the UK the more commonly used term is "centre of excellence". [2]

Contents

Background

In the mid-1980s the need for centers of excellence for rare diseases was expressed in the United States, which in 1999 led the NIH to endorse a proposal for incremental establishment until 40 centers were established. The NIH panel also stressed the importance of centers working closely with patient advocacy groups. [3] Similar needs were identified in Europe in December 1993, when experts in consultation with the European Commission identified five priority areas for public health, among which there was “an EU programme for management of rare diseases”. [4] This was followed by the recommendation of 8 June 2009 of the Council of the European Union, outlining an action in the field of rare diseases whereby EU member states are encouraged to elaborate a plan or strategy for rare diseases by the end of 2013. [5] The strategy would include Centers of Expertise as a core element of all National Plans on Rare Diseases. The Centers would be expected to collaborate closely with patient organizations and other stakeholders. [1] Soon after, the General Director of the World Health Organization expressed interest in taking action on rare diseases and included rare disease patients in the Sustainable Development Goals vision since February 2018. [6] In this direction, a memorandum of understanding was signed between the WHO and Rare Diseases International on establishing the Collaborative Global Network for Rare Diseases (CGN4RD) with the ultimate goal of identifying and connecting centers of expertise internationally in one global network within the scope of WHO’s 13th General Programme of Work 2019-2023. [7] [8]

Centers of expertise by region and country

Europe

In Europe, the organization responsible for providing information on centers of expertise for rare diseases or networks thereof is Orphanet. The organization maintains a database of centers which fulfill the eligibility criteria laid out by the European Union Committee of Experts on Rare Diseases. [9]

See also

Related Research Articles

A rare disease is any disease that affects a small percentage of the population. In some parts of the world, an orphan disease is a rare disease whose rarity means there is a lack of a market large enough to gain support and resources for discovering treatments for it, except by the government granting economically advantageous conditions to creating and selling such treatments. Orphan drugs are ones so created or sold.

An orphan drug is a pharmaceutical agent developed to treat medical conditions which, because they are so rare, would not be profitable to produce without government assistance. The conditions are referred to as orphan diseases.

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is one of the institutes and centers that make up the National Institutes of Health, an agency of the United States Department of Health and Human Services (HHS).

Emergency is a humanitarian NGO that provides free medical treatment to the victims of war, poverty and landmines. It was founded in 1994. Gino Strada, one of the organisation's co-founders, served as EMERGENCY's Executive Director. It operates on the premise that access to high-quality healthcare is a fundamental human right.

European Centre for Disease Prevention and Control Agency of the European Union

The European Centre for Disease Prevention and Control (ECDC) is an agency of the European Union (EU) whose mission is to strengthen Europe's defences against infectious diseases. It covers a wide spectrum of activities, such as: surveillance, epidemic intelligence, response, scientific advice, microbiology, preparedness, public health training, international relations, health communication, and the scientific journal Eurosurveillance.

A patient safety organization (PSO) is a group, institution, or association that improves medical care by reducing medical errors. Common functions of patient safety organizations are data collection and analysis, reporting, education, funding, and advocacy.

European Institute for Health Records

The European Institute for Health Records or EuroRec Institute is a non-profit organization founded in 2002 as part of the ProRec initiative. On 13 May 2003, the institute was established as a non-profit organization under French law. Current President of EuroRec is Prof. Dipak Kalra. The institute is involved in the promotion of high quality Electronic Health Record systems in the European Union. One of the main missions of the institute is to support, as the European authorised certification body, EHRs certification development, testing and assessment by defining functional and other criteria.

The International Network of Health Promoting Hospitals and Health Services (HPH) is a nonprofit, non-governmental organization that was initiated by the World Health Organization (WHO) in 1988. It is also known simply as HPH, or "Health Promoting Hospitals." HPH is based on the settings approach to health promotion philosophy of the WHO as outlined in the WHO Ottawa Charter for Health Promotion. The organization's main aim is to improve the health gain of hospitals and health services by a bundle of strategies targeting patients, staff, and the community.

Orphanet is a European website providing information about rare diseases as well as corresponding diagnosis, orphan drugs, clinical trials and expert networks

W. Ian Lipkin Professor, microbiologist, epidemiologist

Walter Ian Lipkin is the John Snow Professor of Epidemiology at the Mailman School of Public Health at Columbia University and a professor of Neurology and Pathology at the College of Physicians and Surgeons at Columbia University. He is also director of the Center for Infection and Immunity, an academic laboratory for microbe hunting in acute and chronic diseases. Lipkin is internationally recognized for his work with West Nile virus, SARS and COVID-19.

European Organisation for Rare Diseases

The European Organisation for Rare Diseases (EURORDIS) is a non-governmental patient-driven alliance of patient organizations and individuals active in the field of rare diseases, that promotes research on rare diseases and commercial development of orphan drugs. EURORDIS is dedicated to improving the quality of life of all people living with rare diseases in Europe. It was founded in 1997; it is supported by its members and by the French Muscular Dystrophy Association (AFM), the European Commission, corporate foundations and the health industry.

European Brain Council

The European Brain Council (EBC) is a coordinating international health organization founded in 2002.

Northern Dimension Partnership in Public Health and Social Well-being

The Northern Dimension Partnership in Public Health and Social Well-being (NDPHS) is a transnational networking platform for strengthening professional connections, sharing and co-creating knowledge, and developing joint activities in public health and social well-being.

National Center for Advancing Translational Sciences An NIH agency of the US Department of Health and Human Services

The National Center for Advancing Translational Sciences (NCATS) was established in 2012 and is located in Bethesda, Maryland. NCATS is one of 27 institutes and centers of the US National Institutes of Health (NIH), an agency of the US Department of Health and Human Services. The mission of NCATS is to transform scientific discoveries into new treatments and cures for disease that can be delivered faster to patients. The budget provided to NCATS for fiscal year 2018 is $557,373,000.

The European Health Management Association (EHMA) was established in 1982 and is a non-profit membership organisation. Its focus is on health management capacity and capabilities and on supporting the implementation of health policy and practice.

Marshall Summar American geneticist

Marshall L. Summar is a physician, clinical geneticist and academic specializing in the field of genetics and rare disease.

The European Society for Phenylketonuria and Allied Disorders Treated as Phenylketonuria (E.S.PKU) is a Europe-based non-profit organization. It was founded in 1987 by patient-driven associations to help improve the treatment of phenylketonuria (PKU) in Europe.

European Centre of Excellence for Civilian Crisis Management

The European Centre of Excellence for Civilian Crisis Management e.V. (CoE) is based in Berlin. Its task is to enhance civilian crisis management within the framework of the EU Common Security and Defence Policy (CSDP). It is a service provider for its 21 members, the European External Action Service (EEAS) as well as civilian crisis management missions. Currently it has a staff of 16, among them seconded experts from Finland, Italy, Lithuania, the Netherlands and Sweden.

References

  1. 1 2 "2013 EURORDIS Policy factsheet" (PDF). Eurordis. Retrieved 2020-11-04.{{cite web}}: CS1 maint: url-status (link)
  2. ↑ "Centres of Excellence for Rare Diseases (2013)". Rare Disease UK. 2013-02-28. Archived from the original on 2021-01-15. Retrieved 2020-11-24.
  3. ↑ "NIH Centers of Excellence, Rare Diseases Clinical Research Network Overview" (PDF). National Institute of Health reports. Retrieved 2020-11-14.{{cite web}}: CS1 maint: url-status (link)
  4. ↑ Taruscio, Domenica; Gentile, Amalia E.; Evangelista, Teresinha; Frazzica, Rosa G.; Bushby, Kate; Montserrat, Antoni Moliner (April 2014). "Centres of Expertise and European Reference Networks: key issues in the field of rare diseases. The EUCERD Recommendations". Blood Transfusion. 12 (Suppl 3): s621–s625. doi:10.2450/2014.0026-14s. ISSN   1723-2007. PMC   4044812 . PMID   24922304.
  5. ↑ "COUNCIL RECOMMENDATION of 8 June 2009 on an action in the field of rare diseases". Official Journal of the European Union– via eur-lex.europa.eu.
  6. ↑ "Working with the WHO". Rare Diseases International. Retrieved 2020-11-24.
  7. ↑ "An Agreement with the WHO". Rare Diseases International. 2019-12-16. Retrieved 2020-11-24.
  8. ↑ "TrueMed-Rare Disease Company". Sunday, 8 May 2022
  9. ↑ "Orphanet: Expert centres". www.orpha.net. Retrieved 2021-02-05.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.